Global Transforming Growth Factor Beta 1 Market Research Report 2020

Global Transforming Growth Factor Beta 1 Market Research Report 2020

Table of Contents
1 Transforming Growth Factor Beta 1 Market Overview
1.1 Product Overview and Scope of Transforming Growth Factor Beta 1
1.2 Transforming Growth Factor Beta 1 Segment by Type
1.2.1 Global Transforming Growth Factor Beta 1 Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Pirfenidone
1.2.3 Galunisertib
1.2.4 Others
1.3 Transforming Growth Factor Beta 1 Segment by Application
1.3.1 Transforming Growth Factor Beta 1 Sales Comparison by Application: 2020 VS 2026
1.3.2 IPF
1.3.3 Cancer
1.3.4 Others
1.4 Global Transforming Growth Factor Beta 1 Market Size Estimates and Forecasts
1.4.1 Global Transforming Growth Factor Beta 1 Revenue 2015-2026
1.4.2 Global Transforming Growth Factor Beta 1 Sales 2015-2026
1.4.3 Transforming Growth Factor Beta 1 Market Size by Region: 2020 Versus 2026
2 Global Transforming Growth Factor Beta 1 Market Competition by Manufacturers
2.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Manufacturers (2015-2020)
2.2 Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2015-2020)
2.3 Global Transforming Growth Factor Beta 1 Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Transforming Growth Factor Beta 1 Manufacturing Sites, Area Served, Product Type
2.5 Transforming Growth Factor Beta 1 Market Competitive Situation and Trends
2.5.1 Transforming Growth Factor Beta 1 Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Transforming Growth Factor Beta 1 Players (Opinion Leaders)
3 Transforming Growth Factor Beta 1 Retrospective Market Scenario by Region
3.1 Global Transforming Growth Factor Beta 1 Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Transforming Growth Factor Beta 1 Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.3.1 North America Transforming Growth Factor Beta 1 Sales by Country
3.3.2 North America Transforming Growth Factor Beta 1 Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.4.1 Europe Transforming Growth Factor Beta 1 Sales by Country
3.4.2 Europe Transforming Growth Factor Beta 1 Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Transforming Growth Factor Beta 1 Market Facts & Figures by Region
3.5.1 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region
3.5.2 Asia Pacific Transforming Growth Factor Beta 1 Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.6.1 Latin America Transforming Growth Factor Beta 1 Sales by Country
3.6.2 Latin America Transforming Growth Factor Beta 1 Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Transforming Growth Factor Beta 1 Market Facts & Figures by Country
3.7.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country
3.7.2 Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Transforming Growth Factor Beta 1 Historic Market Analysis by Type
4.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Type (2015-2020)
4.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Type (2015-2020)
4.3 Global Transforming Growth Factor Beta 1 Price Market Share by Type (2015-2020)
4.4 Global Transforming Growth Factor Beta 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Transforming Growth Factor Beta 1 Historic Market Analysis by Application
5.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
5.2 Global Transforming Growth Factor Beta 1 Revenue Market Share by Application (2015-2020)
5.3 Global Transforming Growth Factor Beta 1 Price by Application (2015-2020)
6 Company Profiles and Key Figures in Transforming Growth Factor Beta 1 Business
6.1 Roche
6.1.1 Corporation Information
6.1.2 Roche Description, Business Overview and Total Revenue
6.1.3 Roche Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Roche Products Offered
6.1.5 Roche Recent Development
6.2 Shionogi Ltd
6.2.1 Shionogi Ltd Transforming Growth Factor Beta 1 Production Sites and Area Served
6.2.2 Shionogi Ltd Description, Business Overview and Total Revenue
6.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Shionogi Ltd Products Offered
6.2.5 Shionogi Ltd Recent Development
6.3 Acceleron Pharma Inc
6.3.1 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
6.3.2 Acceleron Pharma Inc Description, Business Overview and Total Revenue
6.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Acceleron Pharma Inc Products Offered
6.3.5 Acceleron Pharma Inc Recent Development
6.4 Genzyme Corp
6.4.1 Genzyme Corp Transforming Growth Factor Beta 1 Production Sites and Area Served
6.4.2 Genzyme Corp Description, Business Overview and Total Revenue
6.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Genzyme Corp Products Offered
6.4.5 Genzyme Corp Recent Development
6.5 Isarna Therapeutics GmbH
6.5.1 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Production Sites and Area Served
6.5.2 Isarna Therapeutics GmbH Description, Business Overview and Total Revenue
6.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Isarna Therapeutics GmbH Products Offered
6.5.5 Isarna Therapeutics GmbH Recent Development
6.6 Scholar Rock
6.6.1 Scholar Rock Transforming Growth Factor Beta 1 Production Sites and Area Served
6.6.2 Scholar Rock Description, Business Overview and Total Revenue
6.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Scholar Rock Products Offered
6.6.5 Scholar Rock Recent Development
6.7 Sirnaomics Inc
6.6.1 Sirnaomics Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
6.6.2 Sirnaomics Inc Description, Business Overview and Total Revenue
6.6.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sirnaomics Inc Products Offered
6.7.5 Sirnaomics Inc Recent Development
6.8 Eli Lilly and Co
6.8.1 Eli Lilly and Co Transforming Growth Factor Beta 1 Production Sites and Area Served
6.8.2 Eli Lilly and Co Description, Business Overview and Total Revenue
6.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Eli Lilly and Co Products Offered
6.8.5 Eli Lilly and Co Recent Development
6.9 Formation Biologics Inc
6.9.1 Formation Biologics Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
6.9.2 Formation Biologics Inc Description, Business Overview and Total Revenue
6.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Formation Biologics Inc Products Offered
6.9.5 Formation Biologics Inc Recent Development
6.10 Novartis AG
6.10.1 Novartis AG Transforming Growth Factor Beta 1 Production Sites and Area Served
6.10.2 Novartis AG Description, Business Overview and Total Revenue
6.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Novartis AG Products Offered
6.10.5 Novartis AG Recent Development
7 Transforming Growth Factor Beta 1 Manufacturing Cost Analysis
7.1 Transforming Growth Factor Beta 1 Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Transforming Growth Factor Beta 1
7.4 Transforming Growth Factor Beta 1 Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Transforming Growth Factor Beta 1 Distributors List
8.3 Transforming Growth Factor Beta 1 Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Transforming Growth Factor Beta 1 Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Transforming Growth Factor Beta 1 by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Transforming Growth Factor Beta 1 by Type (2021-2026)
10.2 Transforming Growth Factor Beta 1 Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Transforming Growth Factor Beta 1 by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Transforming Growth Factor Beta 1 by Application (2021-2026)
10.3 Transforming Growth Factor Beta 1 Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Transforming Growth Factor Beta 1 by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Transforming Growth Factor Beta 1 by Region (2021-2026)
10.4 North America Transforming Growth Factor Beta 1 Estimates and Projections (2021-2026)
10.5 Europe Transforming Growth Factor Beta 1 Estimates and Projections (2021-2026)
10.6 Asia Pacific Transforming Growth Factor Beta 1 Estimates and Projections (2021-2026)
10.7 Latin America Transforming Growth Factor Beta 1 Estimates and Projections (2021-2026)
10.8 Middle East and Africa Transforming Growth Factor Beta 1 Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Transforming Growth Factor Beta 1 Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Transforming Growth Factor Beta 1 Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Transforming Growth Factor Beta 1 Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Transforming Growth Factor Beta 1 Manufacturers Covered in This Study
Table 5. Global Transforming Growth Factor Beta 1 Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Transforming Growth Factor Beta 1 Sales Share by Manufacturers (2015-2020)
Table 7. Global Transforming Growth Factor Beta 1 Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Transforming Growth Factor Beta 1 Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Transforming Growth Factor Beta 1 Sales Sites and Area Served
Table 11. Manufacturers Transforming Growth Factor Beta 1 Product Types
Table 12. Global Transforming Growth Factor Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Transforming Growth Factor Beta 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transforming Growth Factor Beta 1 as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Transforming Growth Factor Beta 1 Players
Table 16. Global Transforming Growth Factor Beta 1 Sales (K Units) by Region (2015-2020)
Table 17. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2015-2020)
Table 18. Global Transforming Growth Factor Beta 1 Revenue (Million US$) by Region (2015-2020)
Table 19. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2015-2020)
Table 20. North America Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 21. North America Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 22. North America Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 24. Europe Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 25. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 26. Europe Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Transforming Growth Factor Beta 1 Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Transforming Growth Factor Beta 1 Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region (2015-2020)
Table 32. Latin America Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 33. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 34. Latin America Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Transforming Growth Factor Beta 1 Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Transforming Growth Factor Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country (2015-2020)
Table 40. Global Transforming Growth Factor Beta 1 Sales (K Units) by Type (2015-2020)
Table 41. Global Transforming Growth Factor Beta 1 Sales Share by Type (2015-2020)
Table 42. Global Transforming Growth Factor Beta 1 Revenue (Million US$) by Type (2015-2020)
Table 43. Global Transforming Growth Factor Beta 1 Revenue Share by Type (2015-2020)
Table 44. Global Transforming Growth Factor Beta 1 Price (USD/Unit) by Type (2015-2020)
Table 45. Global Transforming Growth Factor Beta 1 Sales (K Units) by Application (2015-2020)
Table 46. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Table 47. Global Transforming Growth Factor Beta 1 Sales Growth Rate by Application (2015-2020)
Table 48. Roche Transforming Growth Factor Beta 1 Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Roche Main Product
Table 52. Roche Recent Development
Table 53. Shionogi Ltd Transforming Growth Factor Beta 1 Corporation Information
Table 54. Shionogi Ltd Corporation Information
Table 55. Shionogi Ltd Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Shionogi Ltd Main Product
Table 57. Shionogi Ltd Recent Development
Table 58. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Corporation Information
Table 59. Acceleron Pharma Inc Corporation Information
Table 60. Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Acceleron Pharma Inc Main Product
Table 62. Acceleron Pharma Inc Recent Development
Table 63. Genzyme Corp Transforming Growth Factor Beta 1 Corporation Information
Table 64. Genzyme Corp Corporation Information
Table 65. Genzyme Corp Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Genzyme Corp Main Product
Table 67. Genzyme Corp Recent Development
Table 68. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Corporation Information
Table 69. Isarna Therapeutics GmbH Corporation Information
Table 70. Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Isarna Therapeutics GmbH Main Product
Table 72. Isarna Therapeutics GmbH Recent Development
Table 73. Scholar Rock Transforming Growth Factor Beta 1 Corporation Information
Table 74. Scholar Rock Corporation Information
Table 75. Scholar Rock Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Scholar Rock Main Product
Table 77. Scholar Rock Recent Development
Table 78. Sirnaomics Inc Transforming Growth Factor Beta 1 Corporation Information
Table 79. Sirnaomics Inc Corporation Information
Table 80. Sirnaomics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sirnaomics Inc Main Product
Table 82. Sirnaomics Inc Recent Development
Table 83. Eli Lilly and Co Transforming Growth Factor Beta 1 Corporation Information
Table 84. Eli Lilly and Co Corporation Information
Table 85. Eli Lilly and Co Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Eli Lilly and Co Main Product
Table 87. Eli Lilly and Co Recent Development
Table 88. Formation Biologics Inc Transforming Growth Factor Beta 1 Corporation Information
Table 89. Formation Biologics Inc Corporation Information
Table 90. Formation Biologics Inc Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Formation Biologics Inc Main Product
Table 92. Formation Biologics Inc Recent Development
Table 93. Novartis AG Transforming Growth Factor Beta 1 Corporation Information
Table 94. Novartis AG Corporation Information
Table 95. Novartis AG Transforming Growth Factor Beta 1 Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Novartis AG Main Product
Table 97. Novartis AG Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Transforming Growth Factor Beta 1 Distributors List
Table 101. Transforming Growth Factor Beta 1 Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Transforming Growth Factor Beta 1 Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Transforming Growth Factor Beta 1 Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Transforming Growth Factor Beta 1 Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Transforming Growth Factor Beta 1 Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Transforming Growth Factor Beta 1 Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Transforming Growth Factor Beta 1 Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Transforming Growth Factor Beta 1 Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Transforming Growth Factor Beta 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Transforming Growth Factor Beta 1 Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Transforming Growth Factor Beta 1
Figure 2. Global Transforming Growth Factor Beta 1 Sales Market Share by Type: 2020 VS 2026
Figure 3. Pirfenidone Product Picture
Figure 4. Galunisertib Product Picture
Figure 5. Others Product Picture
Figure 6. Global Transforming Growth Factor Beta 1 Consumption Market Share by Application: 2020 VS 2026
Figure 7. IPF
Figure 8. Cancer
Figure 9. Others
Figure 10. Global Transforming Growth Factor Beta 1 Market Size 2015-2026 (US$ Million)
Figure 11. Global Transforming Growth Factor Beta 1 Sales Capacity (K Units) (2015-2026)
Figure 12. Global Transforming Growth Factor Beta 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Transforming Growth Factor Beta 1 Sales Share by Manufacturers in 2020
Figure 14. Global Transforming Growth Factor Beta 1 Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Transforming Growth Factor Beta 1 Revenue in 2019
Figure 16. Transforming Growth Factor Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Transforming Growth Factor Beta 1 Sales Market Share by Region (2015-2020)
Figure 18. Global Transforming Growth Factor Beta 1 Sales Market Share by Region in 2019
Figure 19. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region (2015-2020)
Figure 20. Global Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2019
Figure 21. North America Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 22. North America Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 23. U.S. Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 28. Europe Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 29. Germany Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Transforming Growth Factor Beta 1 Sales Market Share by Region in 2019
Figure 40. Asia Pacific Transforming Growth Factor Beta 1 Revenue Market Share by Region in 2019
Figure 41. China Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 64. Latin America Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 65. Mexico Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Transforming Growth Factor Beta 1 Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Transforming Growth Factor Beta 1 Revenue Market Share by Country in 2019
Figure 73. Turkey Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Transforming Growth Factor Beta 1 Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Transforming Growth Factor Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Transforming Growth Factor Beta 1 by Type (2015-2020)
Figure 80. Sales Market Share of Transforming Growth Factor Beta 1 by Type in 2019
Figure 81. Revenue Share of Transforming Growth Factor Beta 1 by Type (2015-2020)
Figure 82. Revenue Market Share of Transforming Growth Factor Beta 1 by Type in 2019
Figure 83. Global Transforming Growth Factor Beta 1 Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2015-2020)
Figure 85. Global Transforming Growth Factor Beta 1 Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Transforming Growth Factor Beta 1 by Application (2015-2020)
Figure 87. Global Revenue Share of Transforming Growth Factor Beta 1 by Application in 2020
Figure 88. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Shionogi Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Acceleron Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Genzyme Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Isarna Therapeutics GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Scholar Rock Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Sirnaomics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Eli Lilly and Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Formation Biologics Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Transforming Growth Factor Beta 1
Figure 100. Manufacturing Process Analysis of Transforming Growth Factor Beta 1
Figure 101. Transforming Growth Factor Beta 1 Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Transforming Growth Factor Beta 1 Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Transforming Growth Factor Beta 1 Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Transforming Growth Factor Beta 1 Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Transforming Growth Factor Beta 1 Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Transforming Growth Factor Beta 1 Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Transforming Growth Factor Beta 1 Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Transforming Growth Factor Beta 1 Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Transforming Growth Factor Beta 1 Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Transforming Growth Factor Beta 1 Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Transforming Growth Factor Beta 1 Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs